Back to top

Xenetic says PeriNess enters clinical study agreement for DNase Platform

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corporate executives informed on what's moving stocks. Sign up for a free trial at thefly.com to see what Wall Street is buzzing about.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Xenetic Biosciences, Inc. (XBIO)